Globotriaosyl ceramide modulates interferon-α-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells

Glycoconjugate Journal

Volumn 16, Issue 12, 1999, Pages 821-828

  Maloney, Mark D ^a   Binnington Boyd, Beth ^b   Lingwood, Clifford A ^b,c  

^a SPELMAN COLLEGE   (United States)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

B lymphocytes; CD77; Cell Surface Molecules; Cytokines; FACS; Glycosphingolipid

Indexed keywords

CD19 ANTIGEN; GAMMA INTERFERON; GLOBOTRIAOSYLCERAMIDE;

ANTIGEN EXPRESSION; ARTICLE; BURKITT LYMPHOMA; CONTROLLED STUDY; CYTOTOXICITY; DAUDI CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIGENS, CD19; BINDING SITES; BURKITT LYMPHOMA; CELL DIVISION; HUMANS; INTERFERON ALFA-2B; MUTATION; SHIGA TOXINS; SIGNAL TRANSDUCTION; TRIHEXOSYLCERAMIDES; TUMOR CELLS, CULTURED;

EID: 0033288203     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007145420116     Document Type: Article

References (57)

1. Induction of cell differentiation in Burkitt lymphoma lines. BLA: A glycolipid marker of B-cell differentiation
2. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype
3. Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells
4. A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody
5. Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus
6. Glycolipid modification of α-interferon binding: Sequence similarity between α-interferon receptor and the verotoxin (Shiga-like toxin) B-subunit
7. Evidence for glycosphingolipid modification of the Type-I-interferon receptor
8. Functional significance of globotriaosyl ceramide in interferon-alpha 2/type I interferon receptor-mediated antiviral activity
9. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: Implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis
10. Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells
11. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen
12. CD77-dependent retrograde transport of CD19 to the nuclear membrane: Functional relationship between CD77 and CD19 during germinal center B cell apoptosis
13. Glycolipid binding of purified and recombinant Escherichia coli-produced verotoxin in vitro
14. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1
15. Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes
16. Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor
17. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules
18. Convergence of CD19 and B cell antigen receptor signals at MEK1 and the ERK2 activation cascade
19. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity
20. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation
21. Role of verotoxin receptors in pathogenesis
22. Two distinct binding sites for globotriaosyl ceramide on verotoxins
23. Structure of the Shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3
24. Alpha-interferon inhibits the expression of heavy chain mu-messenger RNA in Daudi cells
25. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targeting and results in a VT1-like disease in pigs
26. Verotoxin-binding in human renal sections
27. Induction of verotoxin sensitivity in receptor deficient cell lines using the receptor glycolipid globotriosyl ceramide
28. Thin-layer chromatography in bacteriology
29. Detection of gangliosides that bind cholera toxin: Direct binding of 125I-labeled toxin to thin-layer chromatograms
30. Functional properties of human germinal center B cells
31. Life and death in germinal centers (redux)
32. Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development
33. The functional role of B cell antigen receptor stimulation and IL-4 in the generation of human memory B cells from germinal center B cells
34. CD 19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82
35. Engaging CD19 or target of an antiproliferative antibody 1 on human B lymphocytes induces binding of B cells to the interfollicular stroma of human tonsils via integrin alpha 4/beta 1 and fibronection
36. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway
37. Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms
38. Glycolipids as receptors
39. Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic
40. Globotriaosyl ceramide (Gb3) expression in human tumour cells: Intracellular trafficking defines a new retrograde transport pathway from the cell surface to the nucleus, which correlates with sensitivity to verotoxin
41. Alpha interferon: Differential suppression of colony growth from human erythroid, myeloid, and megakaryocytic hematopoietic progenitor cells
42. Importance of glycolipid synthesis for butyric acid-induced sensitization to Shiga toxin and intracellular sorting of toxin in A431 cells
43. Glycolipid modification of a-interferon binding: Sequence similarity between a-interferon receptor and the verotoxin (Shiga-like toxin) B-subunit
44. DNA synthesis in nuclei isolated from Daudi cells: A model to study the antiproliferative mechanisms of interferon-α
45. Cytoskeletal association of human α interferon-receptor complexes in interferon-sensitive and -resistant lymphoblastoid cells
46. IFN-α induces homotypic adhesion and Leu-13 expression in human B lymphoid cells
47. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum
48. Activation of Src family kinase Yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains
49. Up-regulation of neutral glycosphingolipid synthesis upon long term inhibition of ceramide synthesis by fumonisin B1
50. GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells
51. Membrane microdomains and caveolae
52. Interaction of verotoxins with glycosphingolipids
53. Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin
54. Distinct roles for sphingolipids and glycosphingolipids at different stages of neuronal development
55. Bifunctional role of glycosphingolipids
56. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting
57. CD44 selectively associates with active Src family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes